Research by Miraca Life Sciences GI Pathologists to be Presented at Digestive Disease Week

IRVING, Texas--()--Miraca Life Sciences, the nation’s largest independent anatomic pathology lab, is pleased to announce nine posters and one platform presentation highlighting research by the company’s expert GI pathologists that will be featured at the Digestive Disease Week conference, starting May 21 in San Diego. Additionally, Robert M. Genta, MD, Chief of Academic Affairs for Miraca Life Sciences, will moderate a clinical symposium and present a 30-minute talk.

These research activities reflect the ongoing commitment by Miraca Life Sciences and its faculty of subspecialists to further the science of GI pathology. Authors from Miraca Life Sciences are noted below by the link to their profile on the company website.

Platform Presentation on Tuesday, May 24, 10:30–11:20 a.m.: Ethnic Variation of Celiac Disease Prevalence in the United States; authors: Anna Krigel, Peter Green, Robert M. Genta, Kevin O. Turner, Benjamin Lebwohl; presentation time: 10:30–10:45 a.m.

30-Minute Talk and Clinical Symposium on Monday, May 23, 2:00–3:30 p.m.: Diagnosis and Management of Gastric Intestinal Metaplasia; presenter and symposium moderator Robert M. Genta.

Poster of Distinction: Characteristics of DNA Mismatch Repair Status and Tumor Distribution Patterns in Early-Onset Colorectal Cancer Patients; authors: Juliana Yang, Amy Noffsinger, Jayaprakash Sree, Qinghua Yang; will be presented Monday, May 23, 9:30 a.m. 4:00 p.m.; presentation time: noon–2:00 p.m.

The research study described in the following poster supports the recent launch by Miraca Life Sciences of the EoGenius test for eosinophilic esophagitis.

Poster: An esophageal biopsy gene expression score is valid for diagnosis and monitoring treatment for eosinophilic esophagitis in adults; authors: Evan S. Dellon, Ranjitha Veerappan, Sarah R. Selitsky, Joel S. Parker, Leana L. Higgins, RoseMary Beitia, Robert M. Genta, Richard H. Lash; will be presented Tuesday, May 24, 9:30 a.m. 4:00 p.m.; presentation time: noon–2:00 p.m.

Poster: Barrett’s Esophagus: The Inverse Association with Non-Atrophic Helicobacter Gastritis is Stronger than with Atrophic Metaplastic Gastritis; authors: Kevin O. Turner, Robert M. Genta; will be presented Saturday, May 21, 9:30 a.m. 4:00 p.m.; presentation time: noon–2:00 p.m.

Poster: Differences in the Socioeconomic Distributions of Inflammatory Bowel Disease and Microscopic Colitis; authors: Amnon Sonnenberg, Kevin O. Turner, Robert M. Genta; will be presented Monday, May 23, 9:30 a.m. 4:00 p.m.; presentation time: noon–2:00 p.m.

Poster: Ethnic Distribution of Eosinophilic Esophagitis in the United States; authors: Robert M. Genta, Kevin O. Turner, Amnon Sonnenberg; will be presented Monday, May 23, 9:30 a.m. 4:00 p.m.; presentation time: noon–2:00 p.m.

Poster: Ethnic Distribution of Barrett’s Metaplasia in the United States is Inversely Associated with H. pylori Prevalence: authors: Robert M. Genta, Stuart J. Spechler, Amnon Sonnenberg; will be presented Monday, May 23, 9:30 a.m. 4:00 p.m.; presentation time: noon–2:00 p.m.

Poster: Colorectal Cancers With/Without DNA Mismatch Repair Deficiency and Tumor Distribution Patterns from 5,088 Patients; authors: Juliana Yang, Amy Noffsinger, Jayaprakash Sree, Qinghua Yang; will be presented Monday, May 23, 9:30 a.m. 4:00 p.m.; presentation time: noon–2:00 p.m.

Poster: Gastrointestinal Lymphocytic Diathesis (GILD): More than Mere Coincidence; authors: Mauricio Salicru, Kevin O. Turner, Robert M. Genta; will be presented Tuesday, May 24, 9:30 a.m. 4:00 p.m.; presentation time: noon–2:00 p.m.

Poster: Lymphocytic Esophagitis: Clinical Characteristics and Associations in a Series of 499 Unique Patients; authors: Robert M. Genta, Salima Haque, Kevin O. Turner; will be presented Tuesday, May 24, 9:30 a.m. 4:00 p.m.; presentation time: noon–2:00 p.m.

About Miraca Life Sciences

Miraca Life Sciences provides the highest quality anatomic pathology services, primarily in the fields of dermatology, hematology, gastroenterology, urology, and breast health. The company also provides clinical pathology services for therapeutic drug monitoring of certain biologic drugs. The company’s team of more than 90 distinguished expert subspecialists utilizes state-of-the-art pathology laboratories to serve more than 5,500 patients every day. Miraca Life Sciences continuously improves diagnostic precision through consensus-based terminology and criteria, rigorous quality assurance, daily consensus conferences, extensive educational and training activities, and close relationships with clinical partners. Headquartered in Irving, Texas, Miraca Life Sciences is a subsidiary of Miraca Holdings Inc., Japan’s largest clinical diagnostics and laboratory testing service provider. For more information, visit www.MiracaLifeSciences.com.

Contacts

Miraca Life Sciences
Joy Jennings, 214-596-7055
jjennings@MiracaLS.com
214-280-6563 mobile

Release Summary

Miraca Life Sciences is pleased to announce nine posters and one platform presentation highlighting research by the company’s expert GI pathologists at the Digestive Disease Week conference.

#Hashtags

Contacts

Miraca Life Sciences
Joy Jennings, 214-596-7055
jjennings@MiracaLS.com
214-280-6563 mobile